Blog

Oscar Tahuahua: ctDNA could offer hope for NSCLC management

ox.ac.uk/new

Jan 23, 2025, 14:32

Oscar Tahuahua: ctDNA could offer hope for NSCLC management

Oscar Tahuahua, Medical Oncology Fellow at National Cancer Institute (Mexico), shared an article by Nicola Normanno et al. on X:

“ctDNA in NSCLC provides a powerful tool for MRD detection, relapse stratification, and treatment monitoring. Its utility is established, but clinical integration depends on standardized assays, sensitivity, and validation.”

Circulating tumour DNA in early-stage and locally advanced NSCLC: ready for clinical implementation?

Authors: Nicola Normanno, Alessandro Morabito, Anna Maria Rachiglio, Vincenzo Sforza, Lorenza Landi, Emilio Bria, Angelo Delmonte, Federico Cappuzzo & Antonella De Luca

Alessandro Morabito Angelo Delmonte Anna Maria Rachiglio Antonella De Luca cancer cancer monitoring Cancer research clinical integration ctDNA Emilio Bria Federico Cappuzzo Lorenza Landi Lung cancer molecular profiling MRD detection Nicola Normanno NSCLC OncoDaily Oncology Oscar Tahuahua relapse stratification treatment advancements Vincenzo Sforza

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity